Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Skinvisible (SKVI) FCF Margin (2010 - 2026)

Skinvisible's (SKVI) quarterly FCF Margin came in at 43.22% in Q2 2026, up 22700.0% year-over-year from N/an in Q2 2025, and up 362.9% quarter-over-quarter from 16.44% in Q1 2026.

Analysis

Skinvisible (SKVI) FCF Margin (2010 - 2026) Analysis & Trends

Skinvisible has disclosed FCF Margin across 17 years of filings, most recently posting 43.22% for Q2 2026.

  • In Q2 2026, FCF Margin rose 22700.0% year-over-year to 43.22%; the TTM figure through Jun 2026 stood at 19.2% (up 37101.0% YoY), while the FY2025 annual figure was 212.48%, up 18278.0% from the prior year.
  • FCF Margin came in at 43.22% for Q2 2026 at Skinvisible, up from 16.44% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 80.26% in Q2 2022 to a low of 1044.8% in Q1 2023.
  • Average FCF Margin over 5 years is 285.0%, with a median of 214.8% recorded in 2024.
  • Year-over-year, FCF Margin tumbled 98153 bps in 2022 and jumped 84384 bps in 2023.
  • Over 5 years, FCF Margin stood at 920.7% in 2022, then jumped by 92 bps to 76.86% in 2023, then sank by 340 bps to 338.24% in 2024, then soared by 112 bps to 39.5% in 2025, then rose by 9 bps to 43.22% in 2026.
  • Per Business Quant data, the three most recent FCF Margin figures were 43.22% in Q2 2026, 16.44% in Q1 2026, and 39.5% in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 647.06 Bn 626.30 Bn 17.26 Bn 28.82%
2 AbbVie 440.06 Bn 433.49 Bn 12.70 Bn 18.33%
3 Merck 364.19 Bn 357.05 Bn 12.21 Bn 26.96%
4 Novartis Ag 268.45 Bn 260.76 Bn 11.24 Bn 43.05%
5 Pfizer 158.40 Bn 146.70 Bn 10.94 Bn 2.01%
6 Sanofi 52.57 Bn 45.19 Bn 10.79 Bn 25.52%
7 Revolution Medicines 44.32 Bn 44.32 Bn - -
8 Incyte 24.98 Bn 20.44 Bn 1.57 Bn 29.58%
9 United Therapeutics 21.15 Bn 18.49 Bn 683.80 Mn 26.25%
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00 43.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.22%
Mar 31, 2026 -16.44%
Dec 31, 2025 39.50%
Sep 30, 2025 10.50%
Jun 30, 2025 -183.78%
Mar 31, 2025 -634.40%
Dec 31, 2024 -338.24%
Sep 30, 2024 -250.84%
Jun 30, 2024 -561.78%
Mar 31, 2024 -245.82%
Dec 31, 2023 -76.86%
Sep 30, 2023 -96.34%
Jun 30, 2023 -511.80%
Mar 31, 2023 -1,044.80%
Dec 31, 2022 -920.70%
Sep 30, 2022 -353.40%
Jun 30, 2022 80.26%
Mar 31, 2022 -68.26%
Dec 31, 2021 60.83%
Sep 30, 2021 44.65%